MediAsas is a nationwide healthcare protection initiative jointly developed by Bank Negara Malaysia (BNM), the Ministry of Health (MOH), and the Ministry of Finance (MOF). Introduced as the cornerstone of Malaysia’s broader RESET healthcare reform strategy, it establishes a standardized, affordable baseline of medical and health insurance and takaful (MHIT) protection for Malaysians.
The RESET strategy was formulated in response to persistent double-digit medical inflation, which reached approximately 15% in 2024. Rapidly escalating private hospital charges and higher utilisation of healthcare services led to substantial premium adjustments across commercial medical policies, putting coverage at risk of becoming unsustainable for middle-income households. MediAsas addresses these systemic cost pressures through several structural reforms:
MediAsas establishes inclusive eligibility criteria designed to extend essential private healthcare protection to segments of the population who have previously been underserved or priced out of commercial coverage. The regulatory framework significantly broadens entry ages while guaranteeing annual renewal well into retirement.
MediAsas introduces a more accommodating approach to evaluating applicants with stable, well-managed pre-existing medical conditions who are typically declined under standard commercial underwriting. While traditional policies often reject applicants outright for minor chronic histories, BNM’s framework enables individuals with managed conditions to secure meaningful hospitalisation protection.
Under the underwriting guidelines, individuals living with controlled chronic illnesses, single-vessel heart disease, early-stage cancer in remission, and mild-to-moderate neurodevelopmental conditions (such as autism) may be accepted into the scheme. The risk-sharing model operates on transparent principles:
MediAsas is structured into two standardized plan tiers—MediAsas Teras and MediAsas Fleksi—catering to different levels of healthcare protection and cost-sharing preferences. Teras provides accessible everyday inpatient protection, while Fleksi serves as an enhanced high-deductible safety net.
MediAsas Teras provides an annual limit of RM100,000, which automatically increases to RM150,000 once the policyholder reaches age 60. Based on 2024 claims data from Insurance Services Malaysia (ISM), RM100,000 is sufficient to cover more than 99% of typical annual private inpatient treatment episodes in Malaysia. It features a manageable per-episode deductible of RM500 for individuals below age 60, and RM1,000 for those aged 60 and above.
MediAsas Fleksi offers an expanded annual limit of RM300,000, accompanied by a higher annual deductible ranging between RM10,000 and RM15,000. This tier is calibrated for individuals seeking a catastrophic safety net to complement an existing corporate medical card or personal emergency savings.
| Feature | MediAsas Teras | MediAsas Fleksi | Traditional Investment-Linked Medical Card |
|---|---|---|---|
| Primary Purpose | Affordable base hospitalisation coverage | High-limit catastrophic inpatient safety net | Comprehensive medical coverage bundled with investment funds |
| Annual Limit | RM100,000 (< age 60) RM150,000 (age 60+) |
RM300,000 | RM1,000,000 to RM5,000,000+ |
| Lifetime Limit | None | None | Commonly none |
| Deductible Structure | RM500 per episode (<60) RM1,000 per episode (60+) |
RM10,000 to RM15,000 annual deductible | Zero deductible, or optional copayment/deductible riders |
| Policy Structure | Standalone (100% protection) | Standalone (100% protection) | Bundled with investment unit funds |
| Premium Sustainability | Pure risk pricing; no investment lapse risk | Pure risk pricing; stabilized by high deductible | Susceptible to fund depletion and steep premium increases with age |
| Hospital Network | Preferred cost-efficient panel hospitals (DRG billing) | Preferred cost-efficient panel hospitals (DRG billing) | Broad private hospital network (mostly fee-for-service) |
Under BNM guidelines, MediAsas is offered in both conventional insurance and Shariah-compliant family takaful variants. Both options deliver identical medical benefits, claim limits, deductibles, and guaranteed renewability provisions, ensuring that consumer protection remains uniform across the industry.
The distinction lies in the governance framework and financial mechanism underpinning the contract:
MediAsas is structured to keep healthcare premiums affordable and transparent by removing intermediary commissions, administrative complexity, and investment loadings. Premiums are age-banded based on pure mortality and morbidity risk.
| Age Band (Age Last Birthday) | Indicative Monthly Premium (MediAsas Teras) | Indicative Monthly Premium (MediAsas Fleksi) |
|---|---|---|
| 30 days – 18 years | RM60 – RM75 | RM35 – RM50 |
| 19 – 30 years | RM65 – RM90 | RM40 – RM60 |
| 31 – 45 years | RM100 – RM160 | RM65 – RM110 |
| 46 – 55 years | RM180 – RM280 | RM120 – RM190 |
| 56 – 65 years | RM300 – RM420 | RM200 – RM310 |
| 66 – 70 years (Entry Max) | RM450 – RM550 | RM320 – RM430 |
Note: The figures above reflect indicative baseline premium estimates compiled during BNM’s stakeholder consultations and pilot testing. Actual final premiums may vary slightly across licensed underwriting operators upon nationwide rollout.
To ensure policyholders can maintain their protection without straining monthly household cash flows, BNM and participating operators support flexible payment options:
MediAsas is designed for simple, transparent digital enrolment through participating licensed life insurers and family takaful operators approved under BNM’s framework. During the current pilot phase (concluding in late 2026), testing is underway across selected participant groups and panel hospitals in the Klang Valley, with broad digital and branch onboarding opening nationwide in January 2027.
Consumers looking to apply once the digital channels open can navigate the standard four-step enrolment procedure:
MediAsas is a standardized, standalone medical and health insurance and takaful product initiated by Bank Negara Malaysia (BNM), the Ministry of Health (MOH), and the Ministry of Finance (MOF). As part of the national RESET strategy, it is designed to address medical inflation by providing an unbundled, affordable private healthcare safety net that operates free from investment-linked fund volatility and excessive hospital billing.
Malaysian citizens holding a valid MyKad are eligible to apply between the ages of 30 days and 70 years old (age last birthday). Coverage features guaranteed annual renewability up to age 85, with no lifetime claim limits across both plan tiers. Eligibility is planned to expand to permanent and foreign residents following the nationwide rollout.
Yes, MediAsas adopts more inclusive underwriting compared to traditional private medical cards. Individuals with well-managed, stable chronic illnesses—such as controlled hypertension, single-vessel heart disease, early-stage cancer in remission, or mild autism—can obtain coverage for new and unrelated medical events, although claims directly related to the pre-existing condition may carry targeted exclusions or risk loadings.
MediAsas is a pure standalone protection policy where 100% of premiums fund medical hospitalisation benefits. Unlike investment-linked policies (ILPs), MediAsas does not divert money into unit funds and is not vulnerable to investment volatility, rising insurance charges, or unexpected policy lapses caused by cash-value depletion.
Yes, policyholders can utilize the Employees Provident Fund (EPF) Akaun Sejahtera (Account 2) health withdrawal facility to pay their MediAsas premiums. This option allows individuals and families to maintain vital hospitalisation protection without dipping into daily disposable cash flow.
MediAsas is undergoing a pilot programme in the Klang Valley through October 2026 and is scheduled for full nationwide rollout in January 2027. Once launched, consumers will be able to apply directly online or via official branches of all BNM-licensed life insurers and family takaful operators offering medical products in Malaysia.
This article is for reference only; the actual coverage terms are subject to the policy.
This article is for reference only and is not medical advice. Please consult a registered doctor if you have any concerns.
© 2026 Bowtie Life Insurance Company Limited. All rights reserved.